Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut WWC3 55841 broad.mit.edu 37 X 10106879 10106879 + Missense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chrX:10106879G>A ENST00000380861.4 + 21 3378 c.2987G>A c.(2986-2988)cGg>cAg p.R996Q WWC3_ENST00000454666.1_Missense_Mutation_p.R996Q NM_015691.3 NP_056506.2 Q9ULE0 WWC3_HUMAN WWC family member 3 996 NS(1)|breast(3)|endometrium(10)|kidney(1)|large_intestine(11)|lung(17)|ovary(5)|prostate(1)|skin(2)|upper_aerodigestive_tract(1) 52 CTGCGGCAGCGGTTGGAGGAC 0.701000 10 20 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7578550 7578550 + Missense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr17:7578550G>A ENST00000420246.2 - 5 512 c.380C>T c.(379-381)tCc>tTc p.S127F TP53_ENST00000455263.2_Missense_Mutation_p.S127F|TP53_ENST00000359597.4_Missense_Mutation_p.S127F|TP53_ENST00000269305.4_Missense_Mutation_p.S127F|TP53_ENST00000413465.2_Missense_Mutation_p.S127F|TP53_ENST00000445888.2_Missense_Mutation_p.S127F NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 127 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. S -> C (in a sporadic cancer; somatic mutation).|S -> F (in sporadic cancers; somatic mutation).|S -> P (in sporadic cancers; somatic mutation).|S -> T (in sporadic cancers; somatic mutation).|S -> Y (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.S127F(23)|p.0?(8)|p.S127Y(8)|p.S127C(7)|p.Y126_K132delYSPALNK(6)|p.A129fs*20(3)|p.Y126_N131delYSPALN(3)|p.S34C(2)|p.P128fs*42(2)|p.V73fs*9(1)|p.S127fs*36(1)|p.P128fs*18(1)|p.Y126fs*11(1)|p.S127_Q136del10(1)|p.P13fs*18(1)|p.?(1)|p.S34F(1)|p.A36fs*20(1)|p.S127fs*42(1)|p.Y126fs*18(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GAGGGCAGGGGAGTACTGTAG 0.552000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 15 20 0 0 1 0 0 POLA1 5422 broad.mit.edu 37 X 24753561 24753561 + Missense_Mutation SNP T T A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chrX:24753561T>A ENST00000379068.3 + 18 1922 c.1879T>A c.(1879-1881)Ttt>Att p.F627I POLA1_ENST00000379059.3_Missense_Mutation_p.F621I P09884 DPOLA_HUMAN polymerase (DNA directed), alpha 1, catalytic subunit 621 cell proliferation|DNA replication checkpoint|DNA replication, synthesis of RNA primer|DNA-dependent DNA replication initiation|double-strand break repair via nonhomologous end joining|interspecies interaction between organisms|lagging strand elongation|leading strand elongation|M/G1 transition of mitotic cell cycle|regulation of transcription involved in G1/S phase of mitotic cell cycle|S phase of mitotic cell cycle|telomere maintenance via recombination|telomere maintenance via semi-conservative replication alpha DNA polymerase:primase complex|cytoplasm|nuclear envelope|nuclear matrix|nucleolus|nucleoplasm chromatin binding|DNA-directed DNA polymerase activity|metal ion binding|nucleoside binding breast(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|ovary(2)|skin(2) 11 Clofarabine(DB00631)|Fludarabine(DB01073) ACTGCTAGGTTTTTTCCTTGC 0.393000 25 55 0 0 1 0 0 OPCML 4978 broad.mit.edu 37 11 132527046 132527046 + Silent SNP C C T TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr11:132527046C>T ENST00000331898.7 - 2 914 c.336G>A c.(334-336)ccG>ccA p.P112P OPCML_ENST00000374778.4_Silent_p.P71P|OPCML_ENST00000524381.1_Silent_p.P105P|OPCML_ENST00000541867.1_Silent_p.P112P|OPCML_ENST00000529038.1_5'UTR NM_002545.3 NP_002536.1 Q14982 OPCM_HUMAN opioid binding protein/cell adhesion molecule-like 112 Ig-like C2-type 1. cell adhesion|neuron recognition anchored to membrane|integral to plasma membrane opioid receptor activity endometrium(5)|kidney(1)|large_intestine(12)|lung(17)|ovary(2)|skin(2)|urinary_tract(8) 47 all_hematologic(175;0.019) all_cancers(12;5.86e-24)|all_epithelial(12;2.65e-17)|all_lung(97;2.89e-05)|Lung NSC(97;6.16e-05)|Breast(109;0.000126)|Medulloblastoma(222;0.0269)|all_neural(223;0.0326)|Esophageal squamous(93;0.129) all cancers(11;4.61e-06)|OV - Ovarian serous cystadenocarcinoma(99;0.012) AGCAGGTGTACGGACCTTCGT 0.502000 19 56 0 0 1 0 0 SMARCA4 6597 broad.mit.edu 37 19 11143993 11143993 + Missense_Mutation SNP C C T TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr19:11143993C>T ENST00000358026.2 + 26 3858 c.3574C>T c.(3574-3576)Cgc>Tgc p.R1192C SMARCA4_ENST00000590574.1_Missense_Mutation_p.R1192C|SMARCA4_ENST00000429416.3_Missense_Mutation_p.R1192C|SMARCA4_ENST00000444061.3_Missense_Mutation_p.R1192C|SMARCA4_ENST00000450717.3_Missense_Mutation_p.R1192C|SMARCA4_ENST00000413806.3_Missense_Mutation_p.R1192C|SMARCA4_ENST00000541122.2_Missense_Mutation_p.R1192C|SMARCA4_ENST00000589677.1_Missense_Mutation_p.R1192C|SMARCA4_ENST00000344626.4_Missense_Mutation_p.R1192C NM_001128849.1 NP_001122321.1 P51532 SMCA4_HUMAN SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 1192 Helicase C-terminal. chromatin remodeling|negative regulation of androgen receptor signaling pathway|negative regulation of cell growth|negative regulation of S phase of mitotic cell cycle|negative regulation of transcription from RNA polymerase II promoter|nervous system development|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent nBAF complex|npBAF complex|nuclear chromatin|SWI/SNF complex|WINAC complex androgen receptor binding|ATP binding|DNA binding|DNA-dependent ATPase activity|helicase activity|histone acetyl-lysine binding|identical protein binding|p53 binding|protein N-terminus binding|transcription corepressor activity p.R1192C(1)|p.?(1) adrenal_gland(1)|autonomic_ganglia(1)|breast(6)|central_nervous_system(23)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|liver(4)|lung(60)|ovary(10)|pancreas(7)|prostate(3)|skin(8)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2) 163 all_lung(6;0.0512)|Lung NSC(9;0.0568) CCGAGCCCACCGCATCGGGCA 0.607000 """F, N, Mis""" NSCLC 8 42 0 0 1 0 0 FREM2 341640 broad.mit.edu 37 13 39454427 39454427 + Missense_Mutation SNP C C G rs148812741 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr13:39454427C>G ENST00000280481.7 + 24 9229 c.9013C>G c.(9013-9015)Cta>Gta p.L3005V NM_207361.4 NP_997244.3 Q5SZK8 FREM2_HUMAN FRAS1 related extracellular matrix protein 2 3005 cell communication|homophilic cell adhesion|multicellular organismal development integral to membrane|plasma membrane calcium ion binding NS(1)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(14)|haematopoietic_and_lymphoid_tissue(3)|kidney(8)|large_intestine(35)|lung(39)|ovary(9)|pancreas(2)|prostate(12)|skin(11)|upper_aerodigestive_tract(7)|urinary_tract(2) 148 Lung NSC(96;1.04e-07)|Prostate(109;0.00384)|Breast(139;0.00396)|Lung SC(185;0.0565)|Hepatocellular(188;0.114) all cancers(112;3.32e-07)|Epithelial(112;1.66e-05)|OV - Ovarian serous cystadenocarcinoma(117;0.00154)|BRCA - Breast invasive adenocarcinoma(63;0.00631)|GBM - Glioblastoma multiforme(144;0.0312) CTAGGTCGCTCTAGGCCGAGA 0.388000 17 31 0 0 1 0 0 ABCA12 26154 broad.mit.edu 37 2 215823176 215823176 + Missense_Mutation SNP A A G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr2:215823176A>G ENST00000272895.7 - 41 6161 c.5942T>C c.(5941-5943)aTc>aCc p.I1981T AC072062.1_ENST00000607412.1_RNA|ABCA12_ENST00000389661.4_Missense_Mutation_p.I1663T NM_173076.2 NP_775099.2 Q86UK0 ABCAC_HUMAN ATP-binding cassette, sub-family A (ABC1), member 12 1981 cellular homeostasis|lipid transport integral to membrane ATP binding|ATPase activity NS(3)|breast(5)|central_nervous_system(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(45)|lung(44)|ovary(8)|pancreas(2)|prostate(4)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1) 139 Renal(323;0.127) Epithelial(149;1.01e-05)|all cancers(144;0.00112)|LUSC - Lung squamous cell carcinoma(224;0.00829)|Lung(261;0.011) TAAACTGCTGATTCTAGAGTG 0.388000 25 23 0 0 1 0 0 RP11-114H24.7 0 broad.mit.edu 37 15 78213760 78213760 + RNA SNP C C T rs4886968 by1000genomes TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr15:78213760C>T ENST00000565869.1 + 0 111 RP11-114H24.2_ENST00000567226.1_RNA GTATTGCAGGCGGCCAGCCAG 0.542000 4 73 0 0 1 0 0 FAM208A 23272 broad.mit.edu 37 3 56694986 56694986 + Missense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr3:56694986G>A ENST00000431842.2 - 3 956 c.32C>T c.(31-33)cCt>cTt p.P11L FAM208A_ENST00000493960.2_Missense_Mutation_p.P407L|FAM208A_ENST00000355628.5_Missense_Mutation_p.P407L NM_015224.3 NP_056039.2 Q9UK61 CC063_HUMAN family with sequence similarity 208, member A 407 NS(1)|breast(1)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(4)|lung(11)|prostate(3)|skin(1) 32 CAGTGCTGGAGGGATTTTCTG 0.299000 16 42 0 0 1 0 0 CASQ2 845 broad.mit.edu 37 1 116311162 116311162 + Translation_Start_Site SNP T T C TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr1:116311162T>C ENST00000261448.5 - 1 240 c.1A>G c.(1-3)Atg>Gtg p.M1V CASQ2_ENST00000456138.2_Start_Codon_SNP_p.M1V NM_001232.3 NP_001223.2 O14958 CASQ2_HUMAN calsequestrin 2 (cardiac muscle) 1 heart development|striated muscle contraction sarcoplasmic reticulum lumen calcium ion binding breast(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(9)|skin(1) 18 Lung SC(450;0.211) all_cancers(81;1.25e-06)|all_epithelial(167;1.02e-06)|all_lung(203;8.03e-06)|Lung NSC(69;5.01e-05) Lung(183;0.0171)|Colorectal(144;0.0686)|LUSC - Lung squamous cell carcinoma(189;0.0903)|all cancers(265;0.108)|COAD - Colon adenocarcinoma(174;0.111)|Epithelial(280;0.12) GTTCTCTTCATTTGGGAAAAC 0.453000 6 19 0 0 1 0 0 ZNF157 7712 broad.mit.edu 37 X 47272249 47272249 + Silent SNP A A C TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chrX:47272249A>C ENST00000377073.3 + 4 863 c.777A>C c.(775-777)gcA>gcC p.A259A NM_003446.3 NP_003437.2 P51786 ZN157_HUMAN zinc finger protein 157 259 negative regulation of transcription from RNA polymerase II promoter nucleus DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding central_nervous_system(1)|endometrium(2)|large_intestine(2)|lung(5)|upper_aerodigestive_tract(1) 11 CTGAGAAGGCAACCCTCACGA 0.438000 7 27 0 0 1 0 0 ABHD17A 81926 broad.mit.edu 37 19 1881347 1881347 + Silent SNP A A G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr19:1881347A>G ENST00000292577.7 - 2 652 c.219T>C c.(217-219)cgT>cgC p.R73R ABHD17A_ENST00000590661.1_Silent_p.R73R|ABHD17A_ENST00000250974.9_Silent_p.R73R NM_001130111.1 NP_001123583.1 abhydrolase domain containing 17A GGAAGTCGGCACGCTCCGTCA 0.716000 3 36 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000345146.2_Missense_Mutation_p.R132H|IDH1_ENST00000446179.1_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 30 48 0 0 1 0 0 GRM4 2914 broad.mit.edu 37 6 33996059 33996059 + Missense_Mutation SNP A A C TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr6:33996059A>C ENST00000374181.3 - 9 2696 c.2527T>G c.(2527-2529)Tac>Gac p.Y843D GRM4_ENST00000545715.1_Missense_Mutation_p.Y535D|GRM4_ENST00000544773.1_Missense_Mutation_p.Y674D|GRM4_ENST00000455714.2_Missense_Mutation_p.Y703D|GRM4_ENST00000538487.1_Missense_Mutation_p.Y843D|GRM4_ENST00000374177.3_Missense_Mutation_p.Y727D|GRM4_ENST00000535756.1_Missense_Mutation_p.Y710D NM_001256810.1 NP_001243739.1 Q14833 GRM4_HUMAN glutamate receptor, metabotropic 4 843 activation of MAPK activity|inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway|neuroprotection|neurotransmitter secretion|positive regulation of MAPKKK cascade cytoplasmic vesicle|integral to plasma membrane G-protein coupled receptor activity|glutamate receptor activity NS(1)|breast(1)|endometrium(4)|kidney(4)|large_intestine(9)|liver(1)|lung(19)|ovary(1)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 48 L-Glutamic Acid(DB00142) AGGATGATGTAGACTTTGGGC 0.607000 49 72 0 0 1 0 0 KCNU1 157855 broad.mit.edu 37 8 36694322 36694322 + Silent SNP A A G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr8:36694322A>G ENST00000399881.3 + 14 1414 c.1377A>G c.(1375-1377)ccA>ccG p.P459P NM_001031836.2 NP_001027006.2 A8MYU2 KCNU1_HUMAN potassium channel, subfamily U, member 1 459 RCK N-terminal. voltage-gated potassium channel complex binding|large conductance calcium-activated potassium channel activity|voltage-gated potassium channel activity breast(4)|central_nervous_system(1)|cervix(1)|endometrium(8)|kidney(1)|large_intestine(9)|lung(31)|ovary(1)|urinary_tract(1) 57 KIRC - Kidney renal clear cell carcinoma(67;0.0504)|Kidney(114;0.0634) TTTATCTGCCAAAGATTCCCA 0.423000 15 37 0 0 1 0 0 EPHA5 2044 broad.mit.edu 37 4 66201659 66201659 + Missense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr4:66201659G>A ENST00000273854.3 - 16 3443 c.2843C>T c.(2842-2844)gCa>gTa p.A948V EPHA5_ENST00000511294.1_Missense_Mutation_p.A949V|EPHA5_ENST00000354839.4_Missense_Mutation_p.A926V|EPHA5_ENST00000432638.2_Missense_Mutation_p.A785V NM_004439.5 NP_004430.4 P54756 EPHA5_HUMAN EPH receptor A5 948 cAMP-mediated signaling|neuron development dendrite|external side of plasma membrane|integral to plasma membrane|neuronal cell body|perinuclear region of cytoplasm|rough endoplasmic reticulum ATP binding|transmembrane-ephrin receptor activity autonomic_ganglia(1)|breast(2)|central_nervous_system(1)|endometrium(13)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(25)|liver(1)|lung(76)|ovary(3)|pancreas(1)|prostate(1)|skin(3)|stomach(4)|upper_aerodigestive_tract(2)|urinary_tract(3) 142 CCTGCAGGATGCATTAACCAG 0.403000 TSP Lung(17;0.13) 35 63 0 0 1 0 0 DCAF8L1 139425 broad.mit.edu 37 X 27999088 27999088 + Nonsense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chrX:27999088G>A ENST00000441525.1 - 1 478 c.364C>T c.(364-366)Cga>Tga p.R122* NM_001017930.1 NP_001017930.1 A6NGE4 DC8L1_HUMAN DDB1 and CUL4 associated factor 8-like 1 122 NS(1)|breast(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(10)|lung(24)|ovary(3)|prostate(1)|skin(4)|stomach(1)|urinary_tract(1) 56 CCACCGCATCGTGGACACATC 0.547000 14 27 0 0 1 0 0 ROBO3 64221 broad.mit.edu 37 11 124738751 124738751 + Missense_Mutation SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr11:124738751G>A ENST00000397801.1 + 2 406 c.214G>A c.(214-216)Gat>Aat p.D72N ROBO3_ENST00000538940.1_Missense_Mutation_p.D50N NM_022370.3 NP_071765.2 Q96MS0 ROBO3_HUMAN roundabout, axon guidance receptor, homolog 3 (Drosophila) 72 Ig-like C2-type 1. axon midline choice point recognition integral to membrane receptor activity breast(2)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(17)|ovary(1)|prostate(3)|upper_aerodigestive_tract(1) 35 all_hematologic(175;0.215) Lung NSC(97;0.0177)|all_lung(97;0.0179)|Medulloblastoma(222;0.0425)|Breast(109;0.0481)|all_neural(223;0.112) BRCA - Breast invasive adenocarcinoma(274;1.5e-06)|OV - Ovarian serous cystadenocarcinoma(99;0.0296) GCAGCCGCCAGATCTGCTGGT 0.672000 3 12 0 0 1 0 0 GEMIN5 25929 broad.mit.edu 37 5 154270897 154270897 + Missense_Mutation SNP T T C TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr5:154270897T>C ENST00000285873.7 - 26 4241 c.4166A>G c.(4165-4167)cAa>cGa p.Q1389R NM_001252156.1|NM_015465.4 NP_001239085.1|NP_056280.2 Q8TEQ6 GEMI5_HUMAN gem (nuclear organelle) associated protein 5 1389 ncRNA metabolic process|protein complex assembly|spliceosomal snRNP assembly Cajal body|cytosol|spliceosomal complex protein binding|snRNA binding breast(1)|central_nervous_system(2)|endometrium(5)|kidney(3)|large_intestine(10)|lung(10)|ovary(1)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1) 38 Renal(175;0.00488) Medulloblastoma(196;0.0354)|all_neural(177;0.147) KIRC - Kidney renal clear cell carcinoma(527;0.00112) TTGACTCTTTTGGTGTTGTCG 0.458000 36 55 0 0 1 0 0 WDR62 284403 broad.mit.edu 37 19 36572456 36572456 + Missense_Mutation SNP A A T TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr19:36572456A>T ENST00000401500.2 + 10 1390 c.1355A>T c.(1354-1356)aAa>aTa p.K452I WDR62_ENST00000388999.3_Missense_Mutation_p.K452I|WDR62_ENST00000270301.7_Missense_Mutation_p.K452I NM_001083961.1|NM_173636.4 NP_001077430.1|NP_775907.4 O43379 WDR62_HUMAN WD repeat domain 62 452 cerebral cortex development nucleus cervix(1)|endometrium(8)|kidney(2)|large_intestine(8)|lung(15)|prostate(4)|stomach(2)|urinary_tract(3) 43 Esophageal squamous(110;0.162) LUSC - Lung squamous cell carcinoma(66;0.06) CACTGGCAGAAAAACATCTTC 0.473000 19 79 0 0 1 0 0 RAG2 5897 broad.mit.edu 37 11 36614246 36614246 + Silent SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr11:36614246G>A ENST00000311485.3 - 2 1634 c.1473C>T c.(1471-1473)ccC>ccT p.P491P NM_000536.3|NM_001243785.1|NM_001243786.1 NP_000527.2|NP_001230714.1|NP_001230715.1 P55895 RAG2_HUMAN recombination activating gene 2 491 chromatin modification|pre-B cell allelic exclusion|somatic diversification of immunoglobulins|T cell differentiation in thymus|V(D)J recombination nucleus chromatin binding|DNA binding|endonuclease activity|methylated histone residue binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|phosphatidylinositol-4,5-bisphosphate binding|zinc ion binding breast(1)|endometrium(3)|kidney(1)|large_intestine(1)|lung(18)|ovary(1)|pancreas(2)|prostate(1)|skin(4) 32 all_lung(20;0.226) all_hematologic(20;0.00756) GGACTCTTTGGGGAGTGTGTA 0.448000 Familial Hemophagocytic Lymphohistiocytosis 30 49 0 0 1 0 0 RP11-114H24.7 0 broad.mit.edu 37 15 78213768 78213768 + RNA SNP C C A rs12904130 by1000genomes TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr15:78213768C>A ENST00000565869.1 + 0 111 RP11-114H24.2_ENST00000567226.1_RNA GGCGGCCAGCCAGATCCTTGG 0.542000 4 69 0.184627 0.184627 1 1 0 CCDC108 255101 broad.mit.edu 37 2 219895549 219895549 + Silent SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr2:219895549G>A ENST00000341552.5 - 9 1106 c.1023C>T c.(1021-1023)tgC>tgT p.C341C CCDC108_ENST00000453220.1_Silent_p.C341C|CCDC108_ENST00000441968.1_Silent_p.C341C|CCDC108_ENST00000410037.1_Silent_p.C276C|CCDC108_ENST00000409865.3_Silent_p.C330C NM_194302.2 NP_919278.2 Q6ZU64 CC108_HUMAN coiled-coil domain containing 108 341 integral to membrane structural molecule activity autonomic_ganglia(1)|breast(1)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(18)|liver(1)|lung(34)|ovary(2)|pancreas(1)|prostate(6)|skin(5)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 80 Renal(207;0.0915) Epithelial(149;1.12e-06)|all cancers(144;0.000196)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00942) GCAGCTGGGCGCACTTGGCTG 0.637000 8 25 0 0 1 0 0 IL17REL 400935 broad.mit.edu 37 22 50435799 50435799 + Silent SNP G G A TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr22:50435799G>A ENST00000389983.2 - 13 1188 c.924C>T c.(922-924)agC>agT p.S308S IL17REL_ENST00000341280.5_Silent_p.S308S NM_001001694.2 NP_001001694.2 Q6ZVW7 I17EL_HUMAN interleukin 17 receptor E-like 308 endometrium(1)|large_intestine(1)|lung(3)|pancreas(1) 6 all_cancers(38;5.53e-07)|all_epithelial(38;3.84e-06)|all_lung(38;0.00208)|Breast(42;0.0104)|Lung NSC(38;0.0199)|Ovarian(80;0.0907)|Lung SC(80;0.236) BRCA - Breast invasive adenocarcinoma(115;0.2)|LUAD - Lung adenocarcinoma(64;0.247) CAGGCAGGGAGCTGTGACTTC 0.667000 5 29 0 0 1 0 0 NBPF10 100132406 broad.mit.edu 37 1 145367767 145367767 + Missense_Mutation SNP G G A rs77484671 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr1:145367767G>A ENST00000342960.5 + 83 10398 c.10363G>A c.(10363-10365)Gaa>Aaa p.E3455K NBPF10_ENST00000369338.1_Intron|NBPF10_ENST00000369339.2_Intron NM_001039703.4 NP_001034792.4 A6NDV3 A6NDV3_HUMAN neuroblastoma breakpoint family, member 10 3455 p.E3455K(5) NS(3)|breast(1)|central_nervous_system(3)|endometrium(12)|kidney(23)|lung(15)|ovary(1)|prostate(7)|skin(6)|urinary_tract(2) 73 all_hematologic(923;0.032) Colorectal(1306;1.36e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.00258) atcaaagaaggaaagaagaag 0.423000 3 30 0 0 1 0 0 RARRES2 0 broad.mit.edu 37 7 150037192 150037192 + Silent SNP A A G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr7:150037192A>G ENST00000466675.1 - 2 1309 c.276T>C c.(274-276)aaT>aaC p.N92N RARRES2_ENST00000223271.3_Silent_p.N92N|RARRES2_ENST00000482669.1_Silent_p.N92N Q99969 RARR2_HUMAN retinoic acid receptor responder (tazarotene induced) 2 92 embryonic digestive tract development|in utero embryonic development|positive regulation of macrophage chemotaxis|retinoid metabolic process extracellular matrix receptor binding endometrium(1)|large_intestine(1)|lung(1)|pancreas(1)|skin(1) 5 OV - Ovarian serous cystadenocarcinoma(82;0.011) CACTCACCCCATTGGGCCTGA 0.567000 193 327 0 0 1 0 0 TMX1 81542 broad.mit.edu 37 14 51713855 51713855 + Missense_Mutation SNP G G C TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr14:51713855G>C ENST00000457354.2 + 4 485 c.360G>C c.(358-360)aaG>aaC p.K120N NM_030755.4 NP_110382.3 Q9H3N1 TMX1_HUMAN thioredoxin-related transmembrane protein 1 120 Thioredoxin. anti-apoptosis|cell proliferation|cell redox homeostasis|DNA replication|electron transport chain|ER to Golgi vesicle-mediated transport|leukocyte activation|positive regulation of growth|positive regulation of transcription, DNA-dependent|response to stress|signal transduction endoplasmic reticulum membrane|integral to membrane|membrane fraction arsenate reductase (thioredoxin) activity|disulfide oxidoreductase activity endometrium(2)|large_intestine(2)|urinary_tract(1) 5 CAAGGACTAAGAAGGACTTCA 0.353000 38 46 0 0 1 0 0 RP11-114H24.7 0 broad.mit.edu 37 15 78211427 78211427 + RNA SNP G G T rs71145882 by1000genomes TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr15:78211427G>T ENST00000565869.1 + 0 111 RP11-114H24.2_ENST00000567226.1_RNA TGCTCTCGGAGCATCTCCTCC 0.587000 6 139 8.12818e-05 8.54501e-05 1 1 0 FAT4 79633 broad.mit.edu 37 4 126239329 126239329 + Missense_Mutation SNP A A G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr4:126239329A>G ENST00000394329.3 + 1 1776 c.1763A>G c.(1762-1764)tAt>tGt p.Y588C NM_024582.4 NP_078858.4 Q6V0I7 FAT4_HUMAN FAT atypical cadherin 4 588 Cadherin 6. homophilic cell adhesion integral to membrane|plasma membrane calcium ion binding NS(6)|autonomic_ganglia(1)|breast(4)|central_nervous_system(3)|cervix(3)|endometrium(27)|haematopoietic_and_lymphoid_tissue(3)|kidney(10)|large_intestine(93)|liver(3)|lung(120)|ovary(9)|pancreas(2)|prostate(21)|skin(31)|stomach(1)|upper_aerodigestive_tract(12)|urinary_tract(6) 355 CCAGAAGGGTATGATGTGTCT 0.532000 35 51 0 0 1 0 0 CASP14 23581 broad.mit.edu 37 19 15166067 15166067 + Missense_Mutation SNP G G A rs148526551 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr19:15166067G>A ENST00000427043.3 + 5 810 c.502G>A c.(502-504)Gtt>Att p.V168I CASP14_ENST00000221740.1_Missense_Mutation_p.V168I NM_012114.2 NP_036246.1 P31944 CASPE_HUMAN caspase 14, apoptosis-related cysteine peptidase 168 apoptosis|cell differentiation|epidermis development|proteolysis cytoplasm|nucleus cysteine-type endopeptidase activity NS(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|prostate(1)|skin(3) 26 TGCCTTGCACGTTTATTCCAC 0.547000 4 48 0 0 1 0 0 KCND1 3750 broad.mit.edu 37 X 48826090 48826090 + Missense_Mutation SNP C C T TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chrX:48826090C>T ENST00000218176.3 - 1 1886 c.589G>A c.(589-591)Gcc>Acc p.A197T NM_004979.4 NP_004970.3 Q9NSA2 KCND1_HUMAN potassium voltage-gated channel, Shal-related subfamily, member 1 197 voltage-gated potassium channel complex metal ion binding|voltage-gated potassium channel activity endometrium(3)|large_intestine(7)|lung(7)|ovary(2)|prostate(1)|skin(1)|soft_tissue(1)|upper_aerodigestive_tract(2) 24 ACCGACACGGCGATGAAGAAG 0.642000 10 8 0 0 1 0 0 RP11-739N20.2 0 broad.mit.edu 37 1 204363980 204363980 + RNA DEL A A - TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr1:204363980delA ENST00000443515.1 + 0 146 tttgtttttcaaaaaaaaaaa 0.308 2 4 --- --- --- --- H1FOO 132243 broad.mit.edu 37 3 129268112 129268113 + Frame_Shift_Ins INS - - G TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr3:129268112_129268113insG ENST00000324382.2 + 3 652_653 c.647_648insG c.(646-648)agtfs p.S216fs H1FOO_ENST00000503977.1_Frame_Shift_Ins_p.S77fs NM_153833.1 NP_722575.1 Q8IZA3 H1FOO_HUMAN H1 histone family, member O, oocyte-specific 216 meiosis|nucleosome assembly cytoplasm|nucleosome DNA binding endometrium(1)|lung(4)|skin(1) 6 GAGGCTAGGAAGGTGCCCCCCA 0.649 3 3 --- --- --- --- CELP 0 broad.mit.edu 37 9 135962465 135962465 + RNA DEL T T - rs63239560 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr9:135962465delT ENST00000411440.2 + 0 972 NR_001275.2 AGGATGCCCCTGTGCCCCTCA 0.677 4 5 --- --- --- --- FOLH1B 219595 broad.mit.edu 37 11 89407164 89407165 + RNA INS - - T rs72449667 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr11:89407164_89407165insT ENST00000532352.1 + 0 1114 Q9HBA9 FOH1B_HUMAN folate hydrolase 1B proteolysis cytoplasm dipeptidase activity|metal ion binding|metallopeptidase activity breast(1)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(7)|lung(26)|ovary(4)|skin(4)|urinary_tract(2) 48 CCATCAATGACTTTTTTTTTTT 0.302 4 8 --- --- --- --- VPS13C 54832 broad.mit.edu 37 15 62302761 62302776 + Frame_Shift_Del DEL CATGTAGAGTTTTGCA CATGTAGAGTTTTGCA - TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx 0c14ddc3-acf0-4f96-bdb6-eb517d1da522 49ca5323-38a1-4786-b6aa-66de49b053a1 g.chr15:62302761_62302776delCATGTAGAGTTTTGCA ENST00000261517.5 - 13 979_994 c.906_921delTGCAAAACTCTACATG c.(904-921)tcfs p.SAKLYM302fs VPS13C_ENST00000395896.4_Frame_Shift_Del_p.SAKLYM302fs|VPS13C_ENST00000249837.3_Frame_Shift_Del_p.SAKLYM259fs|VPS13C_ENST00000395898.3_Frame_Shift_Del_p.SAKLYM259fs NM_020821.2 NP_065872.1 Q709C8 VP13C_HUMAN vacuolar protein sorting 13 homolog C (S. cerevisiae) 302 protein localization NS(3)|breast(4)|endometrium(4)|kidney(9)|large_intestine(26)|lung(46)|ovary(5)|prostate(6)|skin(6)|stomach(5)|upper_aerodigestive_tract(2)|urinary_tract(1) 117 CATAAGGATTCATGTAGAGTTTTGCAGAGGCTGATA 0.352 17 58 --- --- --- ---